Forgot your password? Click here to reset

If you are having trouble accessing your password, please contact HQ@nyssa-pga.org for assistance.

Send someone a link to this article. They'll recieve an email with a your name, a link to the article and an optional message.

NYSSA • The New York State Society of Anesthesiologists, Inc.

Back to "In This Issue"

Volume 77 Number 1

Case Report

Clearing the Confusion: New Multisociety Practice Guidance and a Critical Review of GLP-1RA Literature

As of January 2025, GLP-1RAs, including semaglutide and liraglutide, have been approved for weight loss management, with ongoing studies exploring their benefits when used to treat other metabolic conditions and populations. Given the growing popularity of GLP-1RAs, it is crucial for anesthesiologists to understand their perioperative implications.

You'll have to be logged in to keep reading.

NYSSA Supporter
MLMIC Insurance Company
Endorsed Vendors
Charles J. Sellers & Co MLMIC Insurance Company Weiss Zarett Brofman Sonnenklar & Levy, P.C.

Website design, development and hosting by MAjor Designs